subscribe: Posts | Comments

Breast cancer prevention drugs ‘should be prescribed’

0 comments

Story summarised from BBC News March 28, 2011

A report published in the Lancet Oncology by a panel of cancer experts calls for women at risk of developing breast cancer to be treated with preventative drugs.

In the UK 46,000 women are diagnosed with breast cancer each year.

Drugs such as tamoxifen could reduce the chances of developing breast cancer and the experts suggest that offering the treatment would be similar to the prescription of statins to patients at risk of heart disease.

Both tamoxifen and raloxifene have been approved in the US for the prevention of breast cancer, but tamoxifen is not without side effects and has been linked with womb cancer, blood clots and strokes.

Professor Jack Cuzick, epidemiologist at Queen Mary, University of London and chair of the panel said, “the two drugs should be approved in the UK. The evidence for them is overwhelming.”

The panel agreed that women who had a greater than 4% chance of developing breast cancer in the next 10 years should be offered preventative therapy, but the key challenge would be to identify who is at risk.

The panel suggests breast density is a significant indicator. They say patients with more than 75% “dense breast tissue” had at least four times the risk of developing breast cancer than patients with mainly non-dense tissue.

“Increased breast density is one of the leading risk factors for breast cancer and early trial results suggest that where tamoxifen is shown to decrease density, the risk of cancer decreases,” says Professor Cuzick.

“If this is confirmed in long-term studies, breast density could become a powerful way to identify high-risk women who could benefit from preventive treatments.”

Meg McArthur, senior policy officer at Breakthrough Breast Cancer, has said that,”it is vital that we find effective ways to prevent breast cancer, especially in women with a high risk. However, as preventative therapy may have negative side effects it would not be appropriate for everyone.

“We welcome studies investigating the best treatments to be used for breast cancer prevention. It’s also crucial to identify those at high-risk who would benefit the most from this form of therapy.”

Leave a Reply

Your email address will not be published. Required fields are marked *